IGF1R and hepatocellular carcinoma: For example, miRNA-122 inhibits the tumorigenic properties of hepatocellular carcinoma cells by repressing ADAM10 (a disintegrin and metalloprotease family 10), SRF (serum response factor), and Igf1R (insulin-like growth factor 1 receptor), which promote tumorigenesis [37].